Zydus gets COFEPRIS nod to market Bhava to treat various cancers
Bhava, a Bevacizumab biosimilar and will be marketed in different strengths of 100 mg/4 ml and 400 mg/16 ml
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
metastatic breast cancer
Enhertu shows positive results in DESTINY-Breast06 Phase III trial
Demonstrates statistically significant and clinically meaningful improvement in progression-free survival in HR-positive, HER2-low…
AstraZeneca India gets dual CDSCO approval for Trastuzumab deruxtecan
Additional indications for treatment of HER2 low breast cancer and HER2 positive gastric / gastro-oesophageal cancer
Roche launches new treatment options for women with metastatic breast cancer in India
New personalised medicines offer increased survival benefit and improved quality of life to Indian women with aggressive…